Precigen's (PGEN) Overweight Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a research note released on Wednesday morning, Benzinga reports. Cantor Fitzgerald also issued estimates for Precigen’s FY2024 earnings at ($0.36) EPS. Several other research firms have also recently commented on PGEN. Stifel Nicolaus reissued a buy rating and issued a […]

Related Keywords

Stifel Nicolaus ,Vanguard Group Inc ,Jpmorgan Chase Co ,Iridian Asset Management ,Sanders Morris Harris ,Patient Capital Management ,Opaleye Management Inc ,Precigen Inc ,Cantor Fitzgerald ,Free Report ,Get Free Report ,Capital Management ,Asset Management ,Precigen Daily ,